EMD Millipore Expands Provantage Upstream Bioproduction Services - - BioPharm International

ADVERTISEMENT

EMD Millipore Expands Provantage Upstream Bioproduction Services



EMD Millipore, the life science division of Merck KGaA, reported the expansion of its upstream services into North America as part of its Provantage biodevelopment and clinical supply offering. The company's Massachusetts facilities will now offer upstream capabilities including media and feed screening, small-scale material production, and optimization of conditions for scale-up and technology transfer.

This expansion allows EMD Millipore's North American customers to access the same services European customers have received at the company's GMP biodevelopment center in Martillac, France.

Source: EMD Millipore

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
PDA Announces Technical Report on Drug Shortages
September 9, 2014
Infinity and AbbVie Collaborate to Develop Oncology Drug
September 5, 2014
Merck KGaA Breaks Ground on Facility in China
September 5, 2014
DPT Laboratories Acquires Media Pharmaceuticals' Lakewood Facilities
September 5, 2014
Author Guidelines

Click here